Partner Fund Management LP Increased Cardiovascular Sys Del (CSII) Holding; Vaughan David Investments Trimmed Lockheed Martin (LMT) Stake

April 14, 2018 - By Clifton Ray

Lockheed Martin Corporation (NYSE:LMT) Logo

Partner Fund Management Lp increased Cardiovascular Sys Inc Del (CSII) stake by 23.27% reported in 2017Q4 SEC filing. Partner Fund Management Lp acquired 103,766 shares as Cardiovascular Sys Inc Del (CSII)’s stock declined 5.48%. The Partner Fund Management Lp holds 549,657 shares with $13.02 million value, up from 445,891 last quarter. Cardiovascular Sys Inc Del now has $760.37M valuation. The stock decreased 2.10% or $0.49 during the last trading session, reaching $22.89. About 76,421 shares traded. Cardiovascular Systems, Inc. (NASDAQ:CSII) has declined 21.67% since April 14, 2017 and is downtrending. It has underperformed by 33.22% the S&P500.

Vaughan David Investments Inc decreased Lockheed Martin Corp (LMT) stake by 93.91% reported in 2017Q4 SEC filing. Vaughan David Investments Inc sold 18,781 shares as Lockheed Martin Corp (LMT)’s stock rose 6.55%. The Vaughan David Investments Inc holds 1,219 shares with $391,000 value, down from 20,000 last quarter. Lockheed Martin Corp now has $97.92 billion valuation. The stock decreased 0.08% or $0.28 during the last trading session, reaching $342.6. About 763,124 shares traded. Lockheed Martin Corporation (NYSE:LMT) has risen 26.83% since April 14, 2017 and is uptrending. It has outperformed by 15.28% the S&P500.

Investors sentiment increased to 1.02 in Q4 2017. Its up 0.23, from 0.79 in 2017Q3. It increased, as 17 investors sold CSII shares while 41 reduced holdings. 14 funds opened positions while 45 raised stakes. 26.16 million shares or 5.38% more from 24.82 million shares in 2017Q3 were reported. Point72 Asset Lp owns 367,000 shares. State Of New Jersey Common Pension Fund D accumulated 0% or 15,000 shares. 16,778 are owned by Price T Rowe Md. Mairs And Power has invested 0.02% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Gabelli Funds Ltd Limited Liability Company has 0.03% invested in Cardiovascular Systems, Inc. (NASDAQ:CSII). Ameritas Ptnrs, a Nebraska-based fund reported 2,803 shares. First Quadrant Limited Partnership Ca holds 13,700 shares. Balyasny Asset Mngmt Limited Liability Company, Illinois-based fund reported 15,800 shares. National Bank Of Montreal Can holds 53,889 shares or 0% of its portfolio. 16,175 were reported by First Foundation Advsrs. Thomson Horstmann And Bryant invested 0.46% of its portfolio in Cardiovascular Systems, Inc. (NASDAQ:CSII). Renaissance Ltd Liability has invested 0.02% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Maryland-based Brown Advisory has invested 0% in Cardiovascular Systems, Inc. (NASDAQ:CSII). California Employees Retirement Systems reported 18,600 shares or 0% of all its holdings. D E Shaw & Comm has 0.03% invested in Cardiovascular Systems, Inc. (NASDAQ:CSII).

Partner Fund Management Lp decreased Acorda Therapeutics Inc (NASDAQ:ACOR) stake by 600,736 shares to 3.45 million valued at $74.04M in 2017Q4. It also reduced Blueprint Medicines Corp stake by 762,346 shares and now owns 866,740 shares. Amazon Com Inc (NASDAQ:AMZN) was reduced too.

Among 9 analysts covering Cardiovascular Systems (NASDAQ:CSII), 4 have Buy rating, 2 Sell and 3 Hold. Therefore 44% are positive. Cardiovascular Systems had 25 analyst reports since August 6, 2015 according to SRatingsIntel. Needham maintained the stock with “Strong Buy” rating in Thursday, August 6 report. The stock of Cardiovascular Systems, Inc. (NASDAQ:CSII) earned “Underperform” rating by Bank of America on Thursday, October 8. The firm has “Hold” rating given on Thursday, December 21 by William Blair. The firm earned “Buy” rating on Friday, July 14 by Needham. The stock of Cardiovascular Systems, Inc. (NASDAQ:CSII) earned “Buy” rating by Needham on Thursday, January 26. On Thursday, September 3 the stock rating was downgraded by Zacks to “Sell”. The rating was downgraded by Bank of America to “Underperform” on Wednesday, June 21. Leerink Swann maintained Cardiovascular Systems, Inc. (NASDAQ:CSII) on Thursday, February 8 with “Outperform” rating. The stock has “Buy” rating by Needham on Thursday, August 3. The company was upgraded on Friday, August 21 by Zacks.

Analysts await Lockheed Martin Corporation (NYSE:LMT) to report earnings on April, 24. They expect $3.40 earnings per share, up 13.33% or $0.40 from last year’s $3 per share. LMT’s profit will be $971.80M for 25.19 P/E if the $3.40 EPS becomes a reality. After $4.30 actual earnings per share reported by Lockheed Martin Corporation for the previous quarter, Wall Street now forecasts -20.93% negative EPS growth.

Among 23 analysts covering Lockheed Martin Corporation (NYSE:LMT), 13 have Buy rating, 0 Sell and 10 Hold. Therefore 57% are positive. Lockheed Martin Corporation had 84 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Wolfe Research given on Wednesday, January 27. The firm has “Hold” rating by RBC Capital Markets given on Monday, January 29. The firm has “Neutral” rating by Goldman Sachs given on Wednesday, August 24. The rating was maintained by RBC Capital Markets with “Hold” on Sunday, October 8. The company was downgraded on Tuesday, January 16 by Wells Fargo. The firm has “Buy” rating by Berenberg given on Thursday, March 17. RBC Capital Markets downgraded the stock to “Sector Perform” rating in Thursday, May 19 report. The rating was maintained by RBC Capital Markets on Wednesday, November 15 with “Hold”. On Wednesday, January 20 the stock rating was initiated by Guggenheim with “Buy”. Cowen & Co maintained Lockheed Martin Corporation (NYSE:LMT) on Wednesday, April 26 with “Hold” rating.

Since January 29, 2018, it had 0 insider buys, and 2 selling transactions for $9.28 million activity. Ambrose Richard F sold $2.69 million worth of stock or 7,517 shares. 19,000 shares were sold by HEWSON MARILLYN A, worth $6.59 million.

Lockheed Martin Corporation (NYSE:LMT) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>